- Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
-
Koga A, Matsui T, Takatsu N, Takada Y, Kishi M, Yano Y, Beppu T, Ono Y, Ninomiya K, Hirai F, Nagahama T, Hisabe T, Takaki Y, Yao K, Imaeda H, Andoh A
- KMID: 2417674
- Intest Res.
- 2018 Apr;16(2):223-232.
- doi: 10.5217/ir.2018.16.2.223
BACKGROUND/AIMS: Decreased trough levels of infliximab (TLI) and antibodies to infliximab (ATI) are associated with loss of response (LOR) in Crohn's disease. Two prospective studies were conducted to determine whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk factors for severity of colonic diverticular hemorrhage
-
Kinjo K, Matsui T, Hisabe T, Ishihara H, Kojima T, Chuman K, Yasukawa S, Beppu T, Koga A, Ishikawa S, Kishi M, Takatsu N, Hirai F, Yao K, Ueki T, Washio M
- KMID: 2417658
- Intest Res.
- 2018 Jul;16(3):458-466.
- doi: 10.5217/ir.2018.16.3.458
BACKGROUND/AIMS: Colonic diverticular hemorrhage (DH) was a rare disease until the 1990s, and its incidence has increased rapidly since 2000 in Japan. In recent years, colonic DH has been the... -
- CITED
-
- Close
- SHARE
-
- Close
